Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « monitoring »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
monitored < monitoring < mono  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000014 (2020) Puja Mehta ; Jessica J. MansonWhat Is the Clinical Relevance of TNF Inhibitor Immunogenicity in the Management of Patients With Rheumatoid Arthritis?
000017 (2020) Franziska Düver [Allemagne] ; Benedikt Wei Brich [Allemagne] ; Matthias Eyrich [Allemagne] ; Matthias Wölfl [Allemagne] ; Paul G. Schlegel [Allemagne] ; Verena Wiegering [Allemagne]Viral reactivations following hematopoietic stem cell transplantation in pediatric patients – A single center 11-year analysis
000019 (2020) Martin Michaud [France] ; Florian Catros [France] ; Francis Gaches [France]Usefulness of serum amyloid a protein dosage for monitoring patients receiving tocilizumab.
000054 (2020) Rongda Li [République populaire de Chine] ; Qi Wan [République populaire de Chine] ; Pan Chen [République populaire de Chine] ; Shufen Mao [République populaire de Chine] ; Qiuju Wang [République populaire de Chine] ; Xiaoxin Li [République populaire de Chine] ; Yi Yang [République populaire de Chine] ; Li Dong [République populaire de Chine]Tocilizumab treatment in Felty's syndrome.
000077 (2020) Lei Li [République populaire de Chine] ; Ranran Li [République populaire de Chine] ; Zhixiong Wu [République populaire de Chine] ; Xianghong Yang ; Mingyan Zhao [République populaire de Chine] ; Jiao Liu [République populaire de Chine] ; Dechang Chen [République populaire de Chine]Therapeutic strategies for critically ill patients with COVID-19
000082 (2020) Eun-Jung Park [Corée du Sud] ; Hyungjin Kim [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Yoon-Kyoung Sung [Corée du Sud] ; Han Joo Baek [Corée du Sud] ; Jisoo Lee [Corée du Sud]The use of biological disease-modifying antirheumatic drugs for inflammatory arthritis in Korea: results of a Korean Expert Consensus
000201 (2020) Naomi Serling-Boyd [États-Unis] ; John H. StoneRecent advances in the diagnosis and management of giant cell arteritis.
000206 (2020) Christos Koutsianas ; Konstantinos Thomas ; Dimitrios VassilopoulosReactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
000236 (2020) Laure Elens [Belgique] ; Loralie J. Langman [États-Unis] ; Dennis A. Hesselink ; Stein Bergan [Norvège] ; Dirk Jan A. R. Moes ; Mariadelfina Molinaro [Italie] ; Raman Venkataramanan [États-Unis] ; Florian Lemaitre [France]Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug–Drug Interactions
000274 (2020) Meng Hsuan Kuo [Taïwan] ; Chih-Wei Tseng [Taïwan] ; Chi-Hui Lee [Taïwan] ; Chien-Hsueh Tung [Taïwan] ; Kuo-Chih Tseng [Taïwan] ; Ning-Sheng Lai [Taïwan]Moderate Risk of Hepatitis B Virus Reactivation in HBsAg−/HBcAb+ Carriers Receiving Rituximab for Rheumatoid Arthritis
000299 (2020) Daniel H. Glaser [États-Unis] ; Christina Schutt [États-Unis] ; Kaila Schollaert-Fitch [États-Unis] ; Kathryn Torok [États-Unis]Linear Scleroderma of the Head - Updates in management of Parry Romberg Syndrome and En coup de sabre: A rapid scoping review across subspecialties
000301 (2020) Austin R. Morrison ; Joseph M. Johnson ; Mayur Ramesh ; Patrick Bradley ; Jeffery Jennings ; Zachary R. SmithLetter to the Editor: Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab.
000309 (2020) Florian Moretto ; François-Xavier Catherine ; Clémentine Esteve ; Mathieu Blot [France] ; Lionel Piroth [France]Isolated Anti-HBc: Significance and Management
000386 (2020) Matthew Mankarious [Royaume-Uni] ; Nick C. Matthews [Royaume-Uni] ; John A. Snowden [Royaume-Uni] ; Arun Alfred [Royaume-Uni]Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD)
000445 (2020) A. Charlotte M. T. De Wolf ; Carla A. Herberts ; Marcel H. N. HoefnagelDawn of Monitoring Regulatory T Cells in (Pre-)clinical Studies: Their Relevance Is Slowly Recognised
000462 (2020) Renate U. Wahl ; Marike Leijs [Belgique] ; Arturo Araujo [Royaume-Uni] ; Albert RübbenCorrelative Monitoring of Immune Activation and Tissue Damage in Malignant Melanoma—An Algorithm for Identification of Tolerance Breakage During Immune Checkpoint Inhibitor Therapy of Cancer
000494 (2020) Naoto Sakumura [Japon] ; Hitoshi Irabu [Japon] ; Natsumi Inoue [Japon] ; Mao Mizuta [Japon] ; Masaki Shimizu [Japon]Clinical usefulness of longitudinal IL-6 monitoring in a patient with Takayasu aortitis receiving tocilizumab.
000508 (2020) Diying Shen [République populaire de Chine] ; Hua Song [République populaire de Chine] ; Xiaojun Xu [République populaire de Chine] ; Weiqun Xu [République populaire de Chine] ; Di Wang [République populaire de Chine] ; Juan Liang [République populaire de Chine] ; Meixin Fang [République populaire de Chine] ; Chan Liao [République populaire de Chine] ; Xiaodan Chen [République populaire de Chine] ; Sisi Li [République populaire de Chine] ; Ning Zhao [République populaire de Chine] ; Wei Huang [République populaire de Chine] ; Yongmin Tang [République populaire de Chine]Chimeric antigen receptor T cell therapy can be administered safely under the real-time monitoring of Th1/Th2 cytokine pattern using the cytometric bead array technology for relapsed and refractory acute lymphoblastic leukemia in children.
000552 (2020) Tomasz J. Guzik [Royaume-Uni] ; Saidi A. Mohiddin [Royaume-Uni] ; Anthony Dimarco [Royaume-Uni] ; Vimal Patel [Royaume-Uni] ; Kostas Savvatis [Royaume-Uni] ; Federica M. Marelli-Berg [Royaume-Uni] ; Meena S. Madhur [États-Unis] ; Maciej Tomaszewski [Royaume-Uni] ; Pasquale Maffia [Royaume-Uni] ; Fulvio D'Acquisto [Royaume-Uni] ; Stuart A. Nicklin [Royaume-Uni] ; Ali J. Marian [États-Unis] ; Ryszard Nosalski [Royaume-Uni] ; Eleanor C. Murray [Royaume-Uni] ; Bartlomiej Guzik [Pologne] ; Colin Berry [Royaume-Uni] ; Rhian M. Touyz [Royaume-Uni] ; Reinhold Kreutz [Allemagne] ; Dao Wen Wang [République populaire de Chine] ; David Bhella [Royaume-Uni] ; Orlando Sagliocco [Italie] ; Filippo Crea [Italie] ; Emma C. Thomson [Royaume-Uni] ; Iain B. Mcinnes [Royaume-Uni]COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.
000589 (2020) Zahra Mahmoudjafari ; Maurice Alexander ; Julianna Roddy ; Ryan Shaw ; Terri Lynn Shigle ; Colleen Timlin ; Katie CulosAmerican Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplant and Cellular Therapy Patients in the United States
000605 (2020) Byounghoon Brian Hwang [États-Unis] ; Laurie Engel [États-Unis] ; Said A. Goueli [États-Unis] ; Hicham Zegzouti [États-Unis]A homogeneous bioluminescent immunoassay to probe cellular signaling pathway regulation

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "monitoring" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "monitoring" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    monitoring
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021